Hologic Net Income Applicable To Common Shares from 2010 to 2025

HOLX Stock  USD 65.45  7.35  10.10%   
Hologic Net Income Applicable To Common Shares yearly trend continues to be fairly stable with very little volatility. Net Income Applicable To Common Shares is likely to outpace its year average in 2025. Net Income Applicable To Common Shares is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Income Applicable To Common Shares  
First Reported
2000-12-31
Previous Quarter
-40.5 M
Current Value
90.6 M
Quarterly Volatility
213.9 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 373.1 M, Interest Expense of 74.8 M or Total Revenue of 4.9 B, as well as many indicators such as Price To Sales Ratio of 2.14, Dividend Yield of 0.0 or PTB Ratio of 3.24. Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
  
Check out the analysis of Hologic Correlation against competitors.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Latest Hologic's Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of Hologic over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Hologic's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hologic's overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Slightly volatile
   Net Income Applicable To Common Shares   
       Timeline  

Hologic Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean371,857,938
Geometric Mean221,059,352
Coefficient Of Variation188.32
Mean Deviation507,044,562
Median456,000,000
Standard Deviation700,267,672
Sample Variance490374.8T
Range3B
R-Value0.55
Mean Square Error367795.9T
R-Squared0.30
Significance0.03
Slope80,558,346
Total Sum of Squares7355622.2T

Hologic Net Income Applicable To Common Shares History

2025550.6 M
2024524.4 M
2022456 M
20211.3 B
20201.9 B
20191.1 B
2018-203.6 M

About Hologic Financial Statements

Hologic investors use historical fundamental indicators, such as Hologic's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Hologic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Income Applicable To Common Shares524.4 M550.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.